Brief: Glaxosmithkline Pharmaceuticals Sept-Quarter Consol Profit Falls
28/10/2020 13:56
Oct 28 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* SEPT-QUARTER CONSOL PROFIT 764.7 MILLION RUPEES VERSUS
PROFIT
5.03 BILLION RUPEES YEAR AGO
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 8.79 BILLION
RUPEES
VERSUS 8.82 BILLION RUPEES YEAR AGO
* APPROVED RE-APPOINTMENT OF PUJA THAKUR AS CFO
Source text for Eikon: ID:nBSE9dWrM
Further company coverage: GLAX.NS
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees